Hiroki Tsujioka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiroki Tsujioka has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Kazutaka Saito
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan
4 shared publicationsAkinori Nakayama
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan
3 shared publicationsKiyoshi Setoguchi
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan
3 shared publicationsAsumi Nirazuka
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan
2 shared publicationsKeita Izumi
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan
2 shared publicationsKintaro Hasegawa
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan
2 shared publications
Latest Publications
- 18 September 2025
- Published by Wiley in International Journal of Urology
- Vol. 32 (12) , 1910-1912
Impact of C‐Reactive Protein Kinetics on the Prognosis of the Patient With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin
- 18 September 2025
- Published by Wiley in International Journal of Urology
- Vol. 32 (12) , 1910-1912
Impact of C‐Reactive Protein Kinetics on the Prognosis of the Patient With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin
- 10 December 2024
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 20 (6) , e70013
Comparison of Robot‐Assisted Laparoscopic Prostatectomy Using the Made‐in‐Japan Robotic System Hinotori Versus Da Vinci: A Propensity Score‐Matched Analysis
Background: We compared the surgical outcomes of patients who underwent robot‐assisted radical prostatectomy (RARP) using hinotori with those of patients who underwent RARP using da Vinci Xi through propensity score matching to evaluate the potential benefits and efficacy of hinotori.Methods: Perioperative data of patients who underwent RARP between 2017 and 2023 were retrospectively evaluated.Results: After adjusting for preoperative risk factors, each group comprised 118 propensity score‐matched patients. Both median total operative time and median console time were significantly longer in the hinotori group (median differences, 26 and 23 min, respectively). Although the hinotori group had lower estimated blood loss, no significant differences were noted between the groups in postoperative complications, positive surgical margin rates, 12‐month biochemical recurrence rates, and urinary continence recovery rates.Conclusions: Although RARP requires more time with hinotori, our study demonstrated that RARP can be performed safely and effectively immediately after the installation of hinotori.
- 10 December 2024
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 20 (6) , e70013
Comparison of Robot‐Assisted Laparoscopic Prostatectomy Using the Made‐in‐Japan Robotic System Hinotori Versus Da Vinci: A Propensity Score‐Matched Analysis
Background: We compared the surgical outcomes of patients who underwent robot‐assisted radical prostatectomy (RARP) using hinotori with those of patients who underwent RARP using da Vinci Xi through propensity score matching to evaluate the potential benefits and efficacy of hinotori.Methods: Perioperative data of patients who underwent RARP between 2017 and 2023 were retrospectively evaluated.Results: After adjusting for preoperative risk factors, each group comprised 118 propensity score‐matched patients. Both median total operative time and median console time were significantly longer in the hinotori group (median differences, 26 and 23 min, respectively). Although the hinotori group had lower estimated blood loss, no significant differences were noted between the groups in postoperative complications, positive surgical margin rates, 12‐month biochemical recurrence rates, and urinary continence recovery rates.Conclusions: Although RARP requires more time with hinotori, our study demonstrated that RARP can be performed safely and effectively immediately after the installation of hinotori.
- Open Access
- 31 July 2024
- Published by Wiley in IJU Case Reports
- Vol. 7 (5) , 364-367
Testicular seminoma in transverse testicular ectopia
Introduction: Transverse testicular ectopia is a rare anomaly in which both testes descend toward the same side of the hemiscrotum.Case presentation: A 35‐year‐old man presented with right inguinal enlargement. Computed tomography showed a normal testis in the right hemiscrotum and a 58 mm heterogeneous mass in the right inguinal area. No testis was observed in the left hemiscrotum. The vascular structures extended from the right inguinal mass to the left renal vein. Consequently, the left testicular tumor was diagnosed as transverse testicular ectopia, and a left orchiectomy was performed. The histological diagnosis was seminoma stage pT2. Furthermore, left para‐aortic lymph node metastasis developed 10 months postoperatively. A complete response was obtained after systemic chemotherapy.Conclusion: Awareness of seminomas in transverse testicular ectopia could facilitate appropriate diagnosis and treatment. Furthermore, the location of the lymph node metastasis indicated that the ectopic testis could have originated from the left side.
- 31 July 2024
- Published by Wiley in IJU Case Reports
- Vol. 7 (5) , 364-367
Open AccessTesticular seminoma in transverse testicular ectopia
Introduction: Transverse testicular ectopia is a rare anomaly in which both testes descend toward the same side of the hemiscrotum.Case presentation: A 35‐year‐old man presented with right inguinal enlargement. Computed tomography showed a normal testis in the right hemiscrotum and a 58 mm heterogeneous mass in the right inguinal area. No testis was observed in the left hemiscrotum. The vascular structures extended from the right inguinal mass to the left renal vein. Consequently, the left testicular tumor was diagnosed as transverse testicular ectopia, and a left orchiectomy was performed. The histological diagnosis was seminoma stage pT2. Furthermore, left para‐aortic lymph node metastasis developed 10 months postoperatively. A complete response was obtained after systemic chemotherapy.Conclusion: Awareness of seminomas in transverse testicular ectopia could facilitate appropriate diagnosis and treatment. Furthermore, the location of the lymph node metastasis indicated that the ectopic testis could have originated from the left side.
- Open Access
- 8 November 2022
- Published by Wiley in IJU Case Reports
- Vol. 6 (2) , 97-100
A regressed germ cell tumor discovered secondary to azoospermia
Introduction: Regressed germ cell tumors are a rare disease commonly diagnosed with metastatic symptoms without local symptoms in the testis.Case presentation: A 33‐year‐old man with azoospermia was referred to our hospital. His right testis was slightly swollen, and ultrasonography revealed hypoechogenicity of the right testis with decreased blood flow. Right high orchiectomy was performed. Pathologically, the seminiferous tubules were absent or highly atrophied with vitrification degeneration; however, no neoplastic lesion was confirmed. One‐month post‐surgery, the patient noticed a mass in the left supraclavicular fossa, of which a biopsy revealed seminoma. The patient was diagnosed with a regressed germ cell tumor and underwent systemic chemotherapy.Conclusion: We reported the first case of a regressed germ cell tumor discovered due to complaints of azoospermia.
- 8 November 2022
- Published by Wiley in IJU Case Reports
- Vol. 6 (2) , 97-100
Open AccessA regressed germ cell tumor discovered secondary to azoospermia
Introduction: Regressed germ cell tumors are a rare disease commonly diagnosed with metastatic symptoms without local symptoms in the testis.Case presentation: A 33‐year‐old man with azoospermia was referred to our hospital. His right testis was slightly swollen, and ultrasonography revealed hypoechogenicity of the right testis with decreased blood flow. Right high orchiectomy was performed. Pathologically, the seminiferous tubules were absent or highly atrophied with vitrification degeneration; however, no neoplastic lesion was confirmed. One‐month post‐surgery, the patient noticed a mass in the left supraclavicular fossa, of which a biopsy revealed seminoma. The patient was diagnosed with a regressed germ cell tumor and underwent systemic chemotherapy.Conclusion: We reported the first case of a regressed germ cell tumor discovered due to complaints of azoospermia.